Literature DB >> 24664751

Sphingolipids in ocular inflammation.

Annie Y Chan1, Shivani N Mann, Hui Chen, Donald U Stone, Daniel J J Carr, Nawajes A Mandal.   

Abstract

Sphingolipids are essential to cell membrane structure and the development and maintenance of neural tissues. The role of bioactive sphingolipids has been established in numerous cellular events, including cell survival, growth, and apoptosis. Ocular inflammatory and autoimmune diseases involve activation and migration of endothelial cells, neovascularization, and infiltration of immune cells into various tissues. Clinically, the impact and role of sphingolipid-mediated signaling is increasingly being appreciated in the pathogenesis and treatment of diseases ranging from multiple sclerosis to neovascularization in age-related macular degeneration and diabetic retinopathy. In this review, we discuss our current knowledge and understanding of sphingolipid metabolism and signaling associated with the pathogenesis of ocular diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664751      PMCID: PMC7425815          DOI: 10.1007/978-1-4614-3209-8_78

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  41 in total

1.  Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.

Authors:  S Kurose; E Ikeda; M Tokiwa; N Hikita; M Mochizuki
Journal:  Exp Eye Res       Date:  2000-01       Impact factor: 3.467

Review 2.  Bioactive sphingolipids in the modulation of the inflammatory response.

Authors:  Mazen El Alwani; Bill Xingjun Wu; Lina M Obeid; Yusuf A Hannun
Journal:  Pharmacol Ther       Date:  2006-06-08       Impact factor: 12.310

Review 3.  Sphingolipids in inflammation: pathological implications and potential therapeutic targets.

Authors:  Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

4.  Mitomycin C, ceramide, and 5-fluorouracil inhibit corneal haze and apoptosis after PRK.

Authors:  Tae-im Kim; Sun Young Lee; Jhang Ho Pak; Hungwon Tchah; Michael S Kook
Journal:  Cornea       Date:  2006-01       Impact factor: 2.651

5.  Anti-inflammatory effects of FTY720 do not prevent neuronal cell loss in a rat model of optic neuritis.

Authors:  Christian R Rau; Katharina Hein; Muriel B Sättler; Benedikt Kretzschmar; Carina Hillgruber; Bradford L McRae; Ricarda Diem; Mathias Bähr
Journal:  Am J Pathol       Date:  2011-02-26       Impact factor: 4.307

6.  Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization.

Authors:  Bing Xie; Jikui Shen; Aling Dong; Aymen Rashid; Glenn Stoller; Peter A Campochiaro
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

7.  FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations.

Authors:  K Mayer; F Birnbaum; T Reinhard; A Reis; S Braunstein; F Claas; R Sundmacher
Journal:  Br J Ophthalmol       Date:  2004-07       Impact factor: 4.638

8.  Investigation of the role of CD1d-restricted invariant NKT cells in experimental choroidal neovascularization.

Authors:  Kuniaki Hijioka; Koh-Hei Sonoda; Chikako Tsutsumi-Miyahara; Takeshi Fujimoto; Yuji Oshima; Masaru Taniguchi; Tatsuro Ishibashi
Journal:  Biochem Biophys Res Commun       Date:  2008-07-09       Impact factor: 3.575

9.  Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.

Authors:  Volker Teichgräber; Martina Ulrich; Nicole Endlich; Joachim Riethmüller; Barbara Wilker; Cheyla Conceição De Oliveira-Munding; Anna M van Heeckeren; Mark L Barr; Gabriele von Kürthy; Kurt W Schmid; Michael Weller; Burkhard Tümmler; Florian Lang; Heike Grassme; Gerd Döring; Erich Gulbins
Journal:  Nat Med       Date:  2008-03-30       Impact factor: 53.440

10.  Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis.

Authors:  S Anand Trip; Patricio G Schlottmann; Stephen J Jones; Daniel R Altmann; David F Garway-Heath; Alan J Thompson; Gordon T Plant; David H Miller
Journal:  Ann Neurol       Date:  2005-09       Impact factor: 10.422

View more
  1 in total

1.  Analysis of sphingolipid composition in human vitreous from control and diabetic individuals.

Authors:  Lynda A Wilmott; Richard C Grambergs; Jeremy C Allegood; Timothy J Lyons; Nawajes Mandal
Journal:  J Diabetes Complications       Date:  2018-12-14       Impact factor: 2.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.